• 6674 Citations
  • 41 h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Pancreaticoduodenectomy Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

Borderline resectable pancreatic cancer—At the crossroads of precision medicine

Katz, M. H. & Varadhachary, G. R., Jan 1 2019, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Precision Medicine
Pancreatic Neoplasms
3 Citations (Scopus)

Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

Bernard, V., Kim, D. U., San Lucas, F. A., Castillo Arias, J. A., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J., Semaan, A., Guerrero, P. A., Kamyabi, N., Zhao, J., Hurd, M. W., Koay, E. J., Taniguchi, C., Herman, J. M., Javle, M., Wolff, R. A., Katz, M. H., Varadhachary, G. R. & 2 othersMaitra, A. & Alvarez, H. A., Jan 1 2019, In : Gastroenterology. 156, 1, p. 108-118.e4

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Nucleic Acids
Exosomes
Circulating Neoplastic Cells
DNA

Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer

Blando, J., Sharma, A., Higa, M. G., Zhao, H., Vence, L., Yadav, S. S., Kim, J., Sepulveda, A. M., Sharp, M., Maitra, A., Wargo, J., Tetzlaff, M., Broaddus, R., Katz, M. H., Varadhachary, G. R., Overman, M. J., Wang, H., Yee, C., Bernatchez, C., Iacobuzio-Donahue, C. & 3 othersBasu, S., Allison, J. P. & Sharma, P., Jan 29 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 5, p. 1692-1697 6 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Melanoma
Adenocarcinoma
Neoplasms
Therapeutics
gemcitabine
Adenocarcinoma
Drug Therapy
130-nm albumin-bound paclitaxel
Confidence Intervals

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies

Bhatty, M., Kato, S., Piha-Paul, S. A., Naing, A., Subbiah, V., Huang, H. J., Karp, D. D., Tsimberidou, A. M., Zinner, R. G., Hwu, W-J., Javle, M., Patel, S. P., Hu, M. I-N., Varadhachary, G. R., Conley, A. P., Ramzanali, N. M., Holley, V. R., Kurzrock, R., Meric-Bernstam, F., Kwang Chae, Y. & 3 othersKim, K. B., Falchook, G. S. & Janku, F., Feb 1 2019, In : Cancer. 125, 3, p. 463-472 10 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Mitogen-Activated Protein Kinase Kinases
Neoplasms